409 related articles for article (PubMed ID: 11602489)
1. Risk factors for cardiovascular disease in systemic lupus erythematosus.
Svenungsson E; Jensen-Urstad K; Heimbürger M; Silveira A; Hamsten A; de Faire U; Witztum JL; Frostegård J
Circulation; 2001 Oct; 104(16):1887-93. PubMed ID: 11602489
[TBL] [Abstract][Full Text] [Related]
2. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease.
Jensen-Urstad K; Svenungsson E; de Faire U; Silveira A; Witztum JL; Hamsten A; Frostegård J
Lupus; 2002; 11(11):744-52. PubMed ID: 12475005
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.
Hua X; Su J; Svenungsson E; Hurt-Camejo E; Jensen-Urstad K; Angelin B; Båvenholm P; Frostegård J
Scand J Rheumatol; 2009; 38(3):184-9. PubMed ID: 19165647
[TBL] [Abstract][Full Text] [Related]
4. Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus.
Ahmad HM; Sarhan EM; Komber U
Rheumatol Int; 2014 May; 34(5):617-23. PubMed ID: 24101173
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
Ammirati E; Bozzolo EP; Contri R; Baragetti A; Palini AG; Cianflone D; Banfi M; Uboldi P; Bottoni G; Scotti I; Pirillo A; Grigore L; Garlaschelli K; Monaco C; Catapano AL; Sabbadini MG; Manfredi AA; Norata GD
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):751-9. PubMed ID: 24787906
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity, oxidized LDL and cardiovascular disease.
Frostegård J
Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
[TBL] [Abstract][Full Text] [Related]
10. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.
Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P
Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus.
Cederholm A; Svenungsson E; Stengel D; Fei GZ; Pockley AG; Ninio E; Frostegård J
Arthritis Rheum; 2004 Sep; 50(9):2869-76. PubMed ID: 15457454
[TBL] [Abstract][Full Text] [Related]
12. Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus.
Liu A; Rahman M; Hafström I; Ajeganova S; Frostegård J
Lupus; 2020 Jul; 29(8):825-835. PubMed ID: 32479241
[TBL] [Abstract][Full Text] [Related]
13. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
[TBL] [Abstract][Full Text] [Related]
14. Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients.
Ajeganova S; Gustafsson T; Lindberg L; Hafström I; Frostegård J
Lupus Sci Med; 2020; 7(1):e000362. PubMed ID: 32095248
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
16. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
17. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J
Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS
Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
